JP2023549051A5 - - Google Patents

Info

Publication number
JP2023549051A5
JP2023549051A5 JP2023524567A JP2023524567A JP2023549051A5 JP 2023549051 A5 JP2023549051 A5 JP 2023549051A5 JP 2023524567 A JP2023524567 A JP 2023524567A JP 2023524567 A JP2023524567 A JP 2023524567A JP 2023549051 A5 JP2023549051 A5 JP 2023549051A5
Authority
JP
Japan
Prior art keywords
azaspiro
octane
hexafluoropropan
carboxylate
carbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023524567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023549051A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/081522 external-priority patent/WO2022101412A1/en
Publication of JP2023549051A publication Critical patent/JP2023549051A/ja
Publication of JP2023549051A5 publication Critical patent/JP2023549051A5/ja
Pending legal-status Critical Current

Links

JP2023524567A 2020-11-13 2021-11-12 Magl阻害剤 Pending JP2023549051A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063113662P 2020-11-13 2020-11-13
US63/113,662 2020-11-13
PCT/EP2021/081522 WO2022101412A1 (en) 2020-11-13 2021-11-12 A magl inhibitor

Publications (2)

Publication Number Publication Date
JP2023549051A JP2023549051A (ja) 2023-11-22
JP2023549051A5 true JP2023549051A5 (https=) 2024-11-20

Family

ID=78709459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023524567A Pending JP2023549051A (ja) 2020-11-13 2021-11-12 Magl阻害剤

Country Status (33)

Country Link
US (2) US11434222B2 (https=)
EP (2) EP4574150A3 (https=)
JP (1) JP2023549051A (https=)
KR (1) KR20230107225A (https=)
CN (2) CN116547274B (https=)
AR (1) AR124057A1 (https=)
AU (1) AU2021379081A1 (https=)
CA (1) CA3196119A1 (https=)
CL (1) CL2023001339A1 (https=)
CO (1) CO2023004649A2 (https=)
CR (1) CR20230203A (https=)
DK (1) DK4244208T3 (https=)
DO (1) DOP2023000086A (https=)
ES (1) ES3025484T3 (https=)
FI (1) FI4244208T3 (https=)
GE (2) GEP20257794B (https=)
HR (1) HRP20250644T1 (https=)
HU (1) HUE071543T2 (https=)
IL (1) IL301818B1 (https=)
JO (1) JOP20230091A1 (https=)
LT (1) LT4244208T (https=)
MA (1) MA62148B1 (https=)
MX (1) MX2023005576A (https=)
PL (1) PL4244208T3 (https=)
PT (1) PT4244208T (https=)
RS (1) RS66839B1 (https=)
SA (1) SA523440403B1 (https=)
SI (1) SI4244208T1 (https=)
TW (1) TWI904281B (https=)
UA (1) UA130186C2 (https=)
UY (1) UY39516A (https=)
WO (1) WO2022101412A1 (https=)
ZA (1) ZA202304134B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
KR20250005229A (ko) 2022-05-04 2025-01-09 하. 룬드벡 아크티에셀스카브 모노아실글리세롤 리파제 억제제로서 1,1,1,3,3,3-헥사플루오로프로판-2-일 (s)-1-(피리다진-3-일카르바모일)-6 아자스피로[2.5]옥탄-6-카르복실레이트의 결정질 형태

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2429991A (en) * 2005-09-07 2007-03-14 Alan Barrows Water powered impulsive unit
US20110172230A1 (en) 2006-08-23 2011-07-14 Takahiro Ishii Urea compound or salt thereof
TW200902007A (en) * 2007-05-25 2009-01-16 Astrazeneca Ab Spirocyclopropyl piperidine derivatives
US20100113465A1 (en) * 2008-10-30 2010-05-06 Pfizer Inc. 7-azaspiro[3.5]nonane-7-carboxamide compounds
US20120083476A1 (en) 2009-06-05 2012-04-05 Janssen Pharmaceutica Nv Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
FR2960875B1 (fr) * 2010-06-04 2012-12-28 Sanofi Aventis Derives de carbamates d'hexafluoroisopropyle, leur preparation et leur application en therapeutique
WO2012047703A2 (en) * 2010-10-04 2012-04-12 Schering Corporation Cyclopropyl-spiro-piperidines useful as sodium channel blockers
US9487495B2 (en) 2012-01-06 2016-11-08 The Scripts Research Institute Carbamate compounds and of making and using same
US9822129B2 (en) * 2012-03-02 2017-11-21 Genentech, Inc. Amido spirocyclic amide and sulfonamide derivatives
MX368615B (es) 2012-09-25 2019-10-09 Hoffmann La Roche Derivados bicíclicos como inhibidores de la autotaxina (atx) que son inhibidores de la producción de ácido lisofosfatídico (lpa) y el uso de los mismos.
CA2917050A1 (en) 2013-07-03 2015-01-08 Todd K. Jones Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
CU24442B1 (es) 2014-04-04 2019-09-04 X Rx Inc Derivados de n-(1-(espirocíclico)oxo) amida sustituidos como inhibidores de autotaxina
ES2878041T3 (es) 2015-03-18 2021-11-18 H Lundbeck As Carbamatos de piperazina y métodos para prepararlos y usarlos
UA121775C2 (uk) 2015-07-31 2020-07-27 Пфайзер Інк. 1,1,1-трифтор-3-гідроксипропан-2-ілкарбаматні похідні та 1,1,1-трифтор-4-гідроксибутан-2-ілкарбаматні похідні як інгібітори magl
EP3340988B1 (en) * 2015-11-12 2025-04-09 Afasci, Inc. Ion channel inhibitory compounds, pharmaceutical formulations and uses
EA036637B1 (ru) 2016-03-31 2020-12-02 Такеда Фармасьютикал Компани Лимитед Гетероциклические спиросоединения, ингибирующие моноацилглицерин-липазу
WO2017197192A1 (en) * 2016-05-12 2017-11-16 Abide Therapeutics, Inc. Spirocycle compounds and methods of making and using same
JOP20190105A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
EP3571202B1 (en) * 2017-01-23 2021-06-30 Pfizer Inc. Heterocyclic spiro compounds as magl inhibitors
CR20200088A (es) * 2017-08-29 2020-04-08 Lundbeck La Jolla Research Center Inc Compuestos espirocíclicos y sus métodos de preparación y uso
JP7257387B2 (ja) * 2017-08-29 2023-04-13 ハー・ルンドベック・アクチエゼルスカベット スピロ環化合物並びにその作製及び使用方法
KR20250005229A (ko) * 2022-05-04 2025-01-09 하. 룬드벡 아크티에셀스카브 모노아실글리세롤 리파제 억제제로서 1,1,1,3,3,3-헥사플루오로프로판-2-일 (s)-1-(피리다진-3-일카르바모일)-6 아자스피로[2.5]옥탄-6-카르복실레이트의 결정질 형태

Similar Documents

Publication Publication Date Title
US11623921B2 (en) Indole carboxamide compounds
JP2023549051A5 (https=)
KR100737090B1 (ko) 축합 이미다졸륨 유도체
JP6505878B2 (ja) Pde4阻害剤としての置換ピリジン及びピラジン化合物
JP5400804B2 (ja) 慢性痛症に活性のある窒素含有二環式化合物
JP2021054843A (ja) トロポミオシン関連キナーゼ(trk)阻害剤
JP2009529047A5 (https=)
KR20160046693A (ko) 횡격막 기능을 향상시키는 방법들
JP2013530951A (ja) ヤヌスキナーゼ阻害剤としてのヘテロ環式化合物
RS52838B (sr) Fenoksimetil heterociklična jedinjenja
WO2023227946A1 (en) Tyk2 inhibitors and uses thereof
HRP20250644T1 (hr) Magl inhibitor
JP2014501772A (ja) タンパク質チロシンキナーゼ阻害薬としての新規スルファミドピペラジン誘導体およびその医薬用途
JP2017504662A (ja) ポリミキシンを含む抗菌剤の組合せ
EP3992185A1 (en) Hydrazone amide derivative and application thereof in preparation of medicaments for preventing and treating alopecia
JP2024539213A (ja) アリール又はヘテロアリール誘導体及びこれを有効成分として含むキナーゼ関連疾患の予防又は治療用薬学的組成物
JP7775288B2 (ja) ピリミジノン化合物およびその使用
JP2004536821A (ja) 新規な置換四環式イミダゾール誘導体、それらの製造法、それらを含む製薬学的組成物及び薬剤としてのそれらの使用
RU2773333C2 (ru) ЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНЫ, ЗАМЕЩЕННЫЕ ИМИДАЗО[1,5-b]ПИРИДАЗИНЫ, РОДСТВЕННЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ПАТОЛОГИЧЕСКИХ СОСТОЯНИЙ
RU2024113309A (ru) Производные пирролидина в качестве ингибиторов ddr
JP2024540916A5 (https=)
ZA200505935B (en) Pyrazolopyridine derivatives
HK1235064B (en) Indole carboxamides compounds useful as kinase inhibitors
HK1235064A1 (en) Indole carboxamides compounds useful as kinase inhibitors
JPH04503515A (ja) 1,4―ジヒドロピリジン類